Latest The Million Women Study Stories
By Megan Rauscher NEW YORK (Reuters Health) - The benefits of physical activity do not extend to reducing the risk of developing ovarian cancer, according to a new study reported in the International Journal of Cancer.
NEW YORK (Reuters Health) - Regular exercise may prevent the mental decline associated with the long-term use of hormone replacement therapy (HRT), preliminary research suggests.
By Clementine Wallace NEW YORK (Reuters Health) - Women who develop lung cancer appear to have lower survival rates if they have a history of using hormone replacement therapy (HRT), a study suggests.
The number of women prescribed Hormone Replacement Therapy (HRT) fell rapidly in the Netherlands after widespread media coverage of the UK's Million Women Study, according to a paper in the December issue of the British Journal of Clinical Pharmacology.
A woman's risk of developing breast cancer while taking hormone replacement therapy may be lower than we think, suggest researchers in this week's BMJ.
GENEVA (Reuters) - Women who take the birth control pill could increase their risk of cervical and breast cancer, scientists said on Friday.
Hormone replacement therapy, which has been linked to an increased risk of breast cancer and stroke, should be used only in the short term to relieve menopausal symptoms, experts warned last night.
HORMONE replacement therapy, which has been linked to an increased risk of breast cancer and strokes, should be used only in the short term to relieve menopausal symptoms, doctors warned yesterday.
THE debate over the value of hormone replacement therapy has raged for the last 30 years. In the early 1990s several studies were published that suggested that HRT had a protective benefit in preventing bone loss that could lead to osteoporosis.
HORMONE Replacement Therapy should only be used to treat the menopause for five years, experts warned yesterday. After that time the risk of taking the drug can outweigh the benefit.